Search

everythinglearnresearchcommunity

for

Search:↓

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

BBR-SA nanomedicine is a safe and effective treatment for breast cancer.

Stopping mitochondrial respiration can prevent brain cancer spread in skin cancer patients, and plant compound β-sitosterol could help achieve this.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

Both treatments are similarly effective, but paclitaxel-carboplatin is cheaper and has more severe side effects.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Vismodegib is effective for basal cell carcinoma but has severe side effects.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

The nanocomposite effectively targets lung cancer cells without harming normal cells.

Sonidegib and vismodegib have different side effects and reporting patterns.

Vismodegib effectively treats advanced basal cell carcinoma but requires careful management of serious side effects.

The combination of encorafenib and binimetinib caused few skin issues.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

SPET-085 effectively inhibits an enzyme linked to prostate issues, similar to finasteride.

Carboplatin-paclitaxel is preferred for advanced lung cancer due to its balance of affordability and patient well-being.

Nanoporous silica entrapped lipid-drug complexes significantly improve the solubility and absorption of drugs that don't dissolve well in water.

Dabrafenib can cause skin growths and sometimes low-grade skin cancer.

Sorafenib may cause hand-foot and stump syndrome, requiring early detection and management.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Sirolimus effectively reduces lesions and improves quality of life in Blue Rubber Bleb Nevus Syndrome with manageable side effects.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Bismuth subgallate and borneol together improve skin wound healing better than when used separately or compared to other treatments.

Two compounds from Asiasarum heterotropoides roots show potential as lung cancer treatments without harming normal cells.

Nobiletin-loaded vesicles effectively treat skin cancer by restoring normal miRNA and antioxidant levels.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.